Freijd et al., 1980 - Google Patents
Spontaneous plaque‐forming human lymphocytes detected with the protein‐A plaque assayFreijd et al., 1980
- Document ID
- 2456183942926919865
- Author
- Freijd A
- Kunori T
- Publication year
- Publication venue
- Scandinavian Journal of Immunology
External Links
Snippet
A sizable proportion of fresh human blood and adenoid lymphocytes were found to produce antibodies when tested in the protein‐A plaque assay of Gronowicz et al. Plaque formation was not caused by release of passively adsorbed immunoglobulin but depended on active …
- 210000004698 Lymphocytes 0 title abstract description 36
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Steere et al. | Correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission | |
Berman et al. | B-lymphocytes activation by the Fc region of IgG. | |
Fauci et al. | Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. | |
BIELORY et al. | Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure | |
US4550086A (en) | Monoclonal antibodies that recognize human T cells | |
Alm et al. | Antibody and immunoglobulin production at the cellular level in bursectomized-irradiated chickens | |
Feldmann et al. | Role of C3 in in vitro lymphocyte cooperation | |
Brochier et al. | Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. | |
Russo et al. | Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies | |
Freijd et al. | Spontaneous plaque‐forming human lymphocytes detected with the protein‐A plaque assay | |
Virji et al. | Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies | |
Hanna et al. | Inhibition of T-and B-lymphocyte functions by normal immunosuppressive protein. | |
Kawachi et al. | Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1‐22‐3 | |
Möller et al. | Mitogenic properties of rabbit anti‐human β2‐microglobulin for murine B cells | |
Wells et al. | Antibodies to human collagen in subjects with selective IgA deficiency | |
Kinnman et al. | Tuberculous meningitis: immune reactions within the central nervous system | |
Melsom et al. | IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life. | |
Ishizaka et al. | Development of hypogammaglobulinaemia in a patient with common variable immunodeficiency | |
Schnaper | A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome | |
Schirrmacher et al. | CYTOTOXIC IMMUNE CELLS WITH SPECIFICITY FOR DEFINED SOLUBLE ANTIGENS: IV. Antibody as Mediator of Specific Cytotoxicity | |
JPH0429358B2 (en) | ||
Clinton et al. | The abrogation of macrophage migration inhibition by pretreatment of immune exudate cells with anti-Θ antibody and complement | |
Kunori et al. | Spontaneous antibody-secreting human blood lymphocytes detected with a protein A plaque assay. | |
Kirkpatrick et al. | Chronic pulmonary disease and immunologic deficiency | |
Pick et al. | Interaction betweensensitized lymphocytes' and antigen in vitro: III. Release of soluble mediators by particulate antigen |